173 related articles for article (PubMed ID: 8386992)
1. The detection of nasopharynx carcinoma in technetium-99m (V) dimercaptosuccinic acid SPECT imaging.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Clin Nucl Med; 1993 Apr; 18(4):321-3. PubMed ID: 8386992
[TBL] [Abstract][Full Text] [Related]
2. Metastatic squamous carcinoma in the neck: an anatomical and physiological study using CT and SPECT 99Tcm (V) DMSA.
Watkinson JC; Lazarus CR; Todd C; Maisey MN; Clarke SE
Br J Radiol; 1991 Oct; 64(766):909-14. PubMed ID: 1659474
[TBL] [Abstract][Full Text] [Related]
3. Imaging of head and neck tumors with technetium(V)-99m DMSA. A new tumor-seeking agent.
Ohta H; Endo K; Fujita T; Nakashima T; Sakahara H; Torizuka K; Shimizu Y; Ishii Y; Makimoto K; Hata N
Clin Nucl Med; 1985 Dec; 10(12):855-60. PubMed ID: 3000682
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the tumor-seeking agent Tc-99m(V) dimercaptosuccinic acid and the renal imaging agent Tc-99m dimercaptosuccinic acid in humans.
Ohta H; Ishii M; Yoshizumi M; Endo K; Sakahara H; Nakajima T; Yomoda I; Masuda H; Horiuchi K; Hata N
Clin Nucl Med; 1985 Mar; 10(3):167-70. PubMed ID: 2985320
[TBL] [Abstract][Full Text] [Related]
5. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA.
Hirano T; Otake H; Yoshida I; Endo K
J Nucl Med; 1995 Feb; 36(2):202-7. PubMed ID: 7830114
[TBL] [Abstract][Full Text] [Related]
6. [Scintigraphic imaging of head and neck cancers with 99m technetium (v) dimercaptosuccinic acid. A prospective clinical study].
Heinritz H; Marienhagen J; Wolf F; Schuster B; Stenglein C; Iro H
HNO; 1992 Nov; 40(11):437-41. PubMed ID: 1335446
[TBL] [Abstract][Full Text] [Related]
7. 99Tcm (v) DMSA: a clinical, planar and SPECT study to evaluate patients with head and neck squamous carcinoma.
Watkinson JC; Lazarus CR; Mistry R; Maisey MN; Clarke SE
Nucl Med Commun; 1990 Feb; 11(2):111-20. PubMed ID: 2162509
[TBL] [Abstract][Full Text] [Related]
8. 99mTechnetium(V) dimercaptosuccinic acid (99mTc(v) DMSA) as a tumour seeking agent in nasopharyngeal carcinoma.
Aw SE; Sundram FX; Goh AS
Ann Acad Med Singap; 1986 Oct; 15(4):498-501. PubMed ID: 3032068
[TBL] [Abstract][Full Text] [Related]
9. 99mTc(V)-dimercaptosuccinic acid scintigraphy in detecting neck metastases in oral squamous cell carcinoma with clinically negative necks.
Zhang Y; Guo C; Yu G; Zhang C
Oral Oncol; 2009 Jun; 45(6):492-5. PubMed ID: 18849187
[TBL] [Abstract][Full Text] [Related]
10. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
[TBL] [Abstract][Full Text] [Related]
11. Detection of cervical lymph node metastases of nasopharyngeal carcinomas with technetium-99m tetrofosmin single photon emission computed tomography and comparison with computed tomography.
Shiau YC; Tsai SC; Wang JJ; Ho YJ; Ho ST; Kao CH
Anticancer Res; 2001; 21(1B):723-6. PubMed ID: 11299833
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m(v) dimercaptosuccinic acid planar scintigraphy in head and neck cancer: clinical, scintigraphic and radiological study.
Watkinson JC; Todd CE; Lazarus CR; Maisey MN; Clarke SE
J Laryngol Otol; 1990 Oct; 104(10):783-9. PubMed ID: 2174074
[TBL] [Abstract][Full Text] [Related]
13. [Application of 99mTc(V)-dimercaptosuccinic acid imaging in detecting neck metastases in patients with oral squamous cell carcinoma].
Zhang Y; Guo CB; Yu GY; Ma DQ; Li Q; Zhang CL
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jul; 39(7):425-8. PubMed ID: 15469116
[TBL] [Abstract][Full Text] [Related]
14. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs.
Kao CH; Wang SJ; Wey SP; Shen LH; Ting G; Yeh SH
Eur J Nucl Med; 1992; 19(10):890-3. PubMed ID: 1333404
[TBL] [Abstract][Full Text] [Related]
15. Detection of cervical lymph node metastases in nasopharyngeal carcinomas: comparison with technetium-99m tetrofosmin single photon emission computed tomography and with magnetic resonance imaging.
Tai CJ; Liu FY; Liang JA; Yang SN; Tsai MH; Kao CH
Anticancer Res; 2003; 23(1B):719-22. PubMed ID: 12680173
[TBL] [Abstract][Full Text] [Related]
16. Value of 99m-Tc MIBI and 99m-Tc(V) DMSA scintigraphy in evaluation of breast mass lesions.
Ambrus E; Rajtár M; Ormándi K; Séra T; Tószegi A; Láng J; Pávics L; Csernay L
Anticancer Res; 1997; 17(3B):1599-605. PubMed ID: 9179201
[TBL] [Abstract][Full Text] [Related]
17. Tc-99m sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid.
Lebouthillier G; Morais J; Picard M; Picard D; Chartrand R; D'Amour P
Clin Nucl Med; 1993 Aug; 18(8):657-61. PubMed ID: 8403695
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the uptake of technetium-99m (v) dimercaptosuccinic acid in patients with squamous carcinoma of the head and neck.
Watkinson JC; Clarke SE; Shaheen OH
Clin Otolaryngol Allied Sci; 1987 Dec; 12(6):405-11. PubMed ID: 2832106
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m (v) dimercaptosuccinic acid uptake in patients with head and neck squamous carcinoma: experience in imaging.
Watkinson JC; Lazarus CR; Mistry R; Shaheen OH; Maisey MN; Clarke SE
J Nucl Med; 1989 Feb; 30(2):174-80. PubMed ID: 2544690
[TBL] [Abstract][Full Text] [Related]
20. 99Tcm (v) DMSA and 67Ga-citrate imaging in patients with head and neck squamous carcinoma: a clinical and scintigraphic study.
Watkinson JC; Lazarus CR; Maisey MN; Clarke SE
Nucl Med Commun; 1990 Feb; 11(2):103-10. PubMed ID: 2162508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]